Blood derivative in-vitro diagnostic substances manufacturing · Maine

LGC Clinical Diagnostics, Inc. MA

Milford, ME · ~109 workers · 4 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.5
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

LGC Clinical Diagnostics, Inc. MA runs at 16% of its industry's injury rate - far safer than the typical Blood derivative in-vitro diagnostic substances manufacturing workplace, earning a grade A.

LGC Clinical Diagnostics, Inc. MA: 0.5 TCR = 16% of Blood derivative in-vitro diagnostic substances manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

LGC Clinical Diagnostics, Inc. MA safety composite

LGC Clinical Diagnostics, Inc. MA scores strongest on total case rate (tcr) (safer than 90% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

78/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0.53 per 100 workers

Safer than 90% of industry peers

DART rate
B 0 per 100 workers

Safer than 84% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−2.1

2021→2024

LGC Clinical Diagnostics, Inc. MA injury rate improved

LGC Clinical Diagnostics, Inc. MA's TCR fell 2.1 from 2.1 in 2021 to 0.0 in 2024. Peak filing year was 2021 at 2.1 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).

2021=2.1 · 2022=0.0 · 2023=0.0 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 325413 · Milford, ME AT/BELOW-IND · MID

Grade A · TCR 0.5 · 16% of ind

  • DART 0.0 DART
  • RANK #1/14
  • PHOTO CMI Carlsbad
  • BOOK 4y book
  • INJ 2 inj
  • SIZE ~109 FTE

Nearest TCR peer: CMI Carlsbad (0.0 TCR gap)

Read with this employer → · Industry book → · Maine employers → · Look up another →

LGC Clinical Diagnostics, Inc. MA in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows LGC Clinical Diagnostics, Inc. MA averages 0.5 TCR (16% of the Blood derivative in-vitro diagnostic substances manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

LGC Clinical Diagnostics, Inc. MA TCR series: 2021=2.1 · 2022=0 · 2023=0 · 2024=0 · BLS 3.3

Where LGC Clinical Diagnostics, Inc. MA falls in its industry

201 Blood derivative in-vitro diag establishments

Safer than 90% of graded establishments in this industry, whose median TCR is 1.4.

More dangerous than peersSafer than peers

Narrower to Maine alone (the establishments it most directly competes with for workers and contracts): ranked #1 safest of 14 Blood derivative in-vitro diag employers in Maine.

LGC Clinical Diagnostics, Inc. MA (109 employees, TCR 0.5) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 02,0004,0006,000 01234 Average employees Total Case Rate LGC Clinical Diagnostics, Inc. MA
LGC Clinical Diagnostics, Inc. MA (109 employees, TCR 0.5) among 29 same-industry peers, split at the industry median of 120 employees and a TCR of 1.4

LGC Clinical Diagnostics, Inc. MA has fewer employees than the Blood derivative in-vitro diagnostic sub median and a lower injury rate than the industry's median TCR of 1.4. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 0.0 0.0 0 0 0
2022 0.0 0.0 0 0 0
2021 2.1 2.1 2 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325413 · ME · Milford

201 Blood derivative in-vitro diagnostic substances manufacturing employers nationwide with a credible TCR · 2,397 rated employers in Maine with headcount on file · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR CMI Carlsbad 0.5 TCR
NAICS-TCR SeraCare Life Sciences, Inc. 0.5 TCR
NAICS-TCR Becton Dickinson Integrated Diagnostic Solutions Baltimore 0.6 TCR
NAICS-TCR Immucor Warren 0.6 TCR
STATE-SIZE N.S. Giles Foundations Inc 109 FTE
STATE-SIZE 8128 109 FTE
STATE-SIZE Westgate Center for Rehabilitation and Alzheimers Care 109 FTE
STATE-SIZE Versant Power Presque Isle Operations Center 108 FTE
NAT-TCR Michels Pacific Energy, Inc- CA- San Diego 0.5 TCR
NAT-TCR Swadley Roof Systems 0.5 TCR
NAT-TCR Enzymedica 0.5 TCR
NAT-TCR GROFF 0.5 TCR
NAT-SIZE Scentsy SC Temps 109 FTE
NAT-SIZE Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) 109 FTE
NAT-SIZE Lexington Operator LLC 109 FTE
NAT-SIZE Deerfield 109 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2021. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.